Serotonin receptor subtype-2B signaling is associated with interleukin-18-induced cardiomyoblast hypertrophy in vitro

[1] Stroumpoulis KI, Pantazopoulos IN, Xanthos TT. Hypertrophic cardiomyopathy and sudden cardiac death. World J Cardiol. 2010; 2:289–98. StroumpoulisKI PantazopoulosIN XanthosTT Hypertrophic cardiomyopathy and sudden cardiac death World J Cardiol 2010 2 289 98 10.4330/wjc.v2.i9.289299882921160605 Search in Google Scholar

[2] Li J, Umar S, Amjedi M, Iorga A, Sharma S, Nadadur RD, et al. New frontiers in heart hypertrophy during pregnancy. Am J Cardiovasc Dis. 2012; 2:192–207. LiJ UmarS AmjediM IorgaA SharmaS NadadurRD New frontiers in heart hypertrophy during pregnancy Am J Cardiovasc Dis 2012 2 192 207 Search in Google Scholar

[3] O’Brien LC, Mezzaroma E, Van Tassell BW, Marchetti C, Carbone S, Abbate A, Toldo S. Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure. Mol Med. 2014; 20:221–9. O’BrienLC MezzaromaE Van TassellBW MarchettiC CarboneS AbbateA ToldoS Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure Mol Med 2014 20 221 9 10.2119/molmed.2014.00034406926924804827 Search in Google Scholar

[4] Wang M, Markel TA, Meldrum DR. Interleukin 18 in the heart. Shock. 2008; 30:3–10. WangM MarkelTA MeldrumDR Interleukin 18 in the heart Shock 2008 30 3 10 10.1097/SHK.0b013e318160f21518562922 Search in Google Scholar

[5] Hartford M, Wiklund O, Hultén LM, Persson A, Karlsson T, Herlitz J, et al. Interleukin-18 as a predictor of future events in patients with acute coronary syndromes. Arterioscler Thromb Vasc Biol. 2010; 30:2039–46. HartfordM WiklundO HulténLM PerssonA KarlssonT HerlitzJ Interleukin-18 as a predictor of future events in patients with acute coronary syndromes Arterioscler Thromb Vasc Biol 2010 30 2039 46 10.1161/ATVBAHA.109.20269720689079 Search in Google Scholar

[6] Badimon L. Interleukin-18: a potent pro-inflammatory cytokine in atherosclerosis. Cardiovasc Res. 2012; 96:172–5. BadimonL Interleukin-18: a potent pro-inflammatory cytokine in atherosclerosis Cardiovasc Res 2012 96 172 5 10.1093/cvr/cvs22622922166 Search in Google Scholar

[7] Colston JT, Boylston WH, Feldman MD, Jenkinson CP, de la Rosa SD, Barton A, et al. Interleukin-18 knockout mice display maladaptive cardiac hypertrophy in response to pressure overload. Biochem Biophys Res Commun. 2007; 354:552–8. ColstonJT BoylstonWH FeldmanMD JenkinsonCP de la RosaSD BartonA Interleukin-18 knockout mice display maladaptive cardiac hypertrophy in response to pressure overload Biochem Biophys Res Commun 2007 354 552 8 10.1016/j.bbrc.2007.01.030184763617250807 Search in Google Scholar

[8] Nebigil CG, Choi D-S, Dierich A, Hickel P, Le Meur M, Messaddeq N, et al. Serotonin 2B receptor is required for heart development. Proc Natl Acad Sci U S A. 2000; 97:9508–13. NebigilCG ChoiD-S DierichA HickelP Le MeurM MessaddeqN Serotonin 2B receptor is required for heart development Proc Natl Acad Sci U S A 2000 97 9508 13 10.1073/pnas.97.17.95081689510944220 Search in Google Scholar

[9] Janssen W, Schymura Y, Novoyatleva T, Kojonazarov B, Boehm M, Wietelmann A, et al. 5-HT2B receptor antagonists inhibit fibrosis and protect from RV heart failure. Biomed Res Int. 2015; 2015:438403. doi: 10.1155/2015/438403 JanssenW SchymuraY NovoyatlevaT KojonazarovB BoehmM WietelmannA 5-HT2B receptor antagonists inhibit fibrosis and protect from RV heart failure Biomed Res Int 2015 2015 438403 10.1155/2015/438403 431257425667920 Open DOISearch in Google Scholar

[10] Nebigil CG, Jaffré F, Messaddeq N, Hickel P, Monassier L, Launay JM, Maroteaux L. Overexpression of the serotonin 5-HT2B receptor in heart leads to abnormal mitochondrial function and cardiac hypertrophy. Circulation. 2003; 107:3223–9. NebigilCG JaffréF MessaddeqN HickelP MonassierL LaunayJM MaroteauxL Overexpression of the serotonin 5-HT2B receptor in heart leads to abnormal mitochondrial function and cardiac hypertrophy Circulation 2003 107 3223 9 10.1161/01.CIR.0000074224.57016.0112810613 Search in Google Scholar

[11] Liang Y-J, Lai L-P, Wang B-W, Juang S-J, Chang C-M, Leu J-G, Shyu K-G. Mechanical stress enhances serotonin 2B receptor modulating brain natriuretic peptide through nuclear factor-κB in cardiomyocytes. Cardiovasc Res. 2006; 72:303–12. LiangY-J LaiL-P WangB-W JuangS-J ChangC-M LeuJ-G ShyuK-G Mechanical stress enhances serotonin 2B receptor modulating brain natriuretic peptide through nuclear factor-κB in cardiomyocytes Cardiovasc Res 2006 72 303 12 10.1016/j.cardiores.2006.08.00316962085 Search in Google Scholar

[12] Jaffré F, Bonnin P, Callebert J, Debbabi H, Setola V, Doly S, et al. Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy. Circ Res. 2009; 104:113–23. JaffréF BonninP CallebertJ DebbabiH SetolaV DolyS Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy Circ Res 2009 104 113 23 10.1161/CIRCRESAHA.108.180976 Search in Google Scholar

[13] Hamblin M, Chang L, Fan Y, Zhang J, Chen YE. PPARs and the cardiovascular system. Antioxid Redox Signal. 2009; 11:1415–52. HamblinM ChangL FanY ZhangJ ChenYE PPARs and the cardiovascular system Antioxid Redox Signal 2009 11 1415 52 10.1089/ars.2008.2280 Search in Google Scholar

[14] Zheng Y, Song HJ, Kim CH, Kim HS, Kim E-G, Sachinidis A, Ahn HY. Inhibitory effect of epigallocatechin 3-O-gallate on vascular smooth muscle cell hypertrophy induced by angiotensin II. J Cardiovasc Pharmacol. 2004; 43:200–8. ZhengY SongHJ KimCH KimHS KimE-G SachinidisA AhnHY Inhibitory effect of epigallocatechin 3-O-gallate on vascular smooth muscle cell hypertrophy induced by angiotensin II J Cardiovasc Pharmacol 2004 43 200 8 10.1097/00005344-200402000-00006 Search in Google Scholar

[15] Won S-M, Park Y-H, Kim H-J, Park K-M, Lee W-J. Catechins inhibit angiotensin II-induced vascular smooth muscle cell proliferation via mitogen-activated protein kinase pathway. Exp Mol Med. 2006; 38:525–34. WonS-M ParkY-H KimH-J ParkK-M LeeW-J Catechins inhibit angiotensin II-induced vascular smooth muscle cell proliferation via mitogen-activated protein kinase pathway Exp Mol Med 2006 38 525 34 10.1038/emm.2006.62 Search in Google Scholar

[16] Villeneuve C, Caudrillier A, Ordener C, Pizzinat N, Parini A, Mialet-Perez J. Dose-dependent activation of distinct hypertrophic pathways by serotonin in cardiac cells. Am J Physiol Heart Circ Physiol. 2009; 297:H821–8. VilleneuveC CaudrillierA OrdenerC PizzinatN PariniA Mialet-PerezJ Dose-dependent activation of distinct hypertrophic pathways by serotonin in cardiac cells Am J Physiol Heart Circ Physiol 2009 297 H821 8 10.1152/ajpheart.00345.2009 Search in Google Scholar

[17] Kimes BW, Brandt BL. Properties of a clonal muscle cell line from rat heart. Exp Cell Res. 1976; 98:367–81. KimesBW BrandtBL Properties of a clonal muscle cell line from rat heart Exp Cell Res 1976 98 367 81 10.1016/0014-4827(76)90447-X Search in Google Scholar

[18] Ayme-Dietrich E, Aubertin-Kirch G, Maroteaux L, Monassier L. Cardiovascular remodeling and the peripheral serotonergic system. Arch Cardiovasc Dis. 2017; 110:51–9. Ayme-DietrichE Aubertin-KirchG MaroteauxL MonassierL Cardiovascular remodeling and the peripheral serotonergic system Arch Cardiovasc Dis 2017 110 51 9 10.1016/j.acvd.2016.08.00228017279 Search in Google Scholar

[19] Cheng K-C, Chang W-T, Li Y, Cheng Y-Z, Cheng J-T, Chen Z-C. GW0742 activates peroxisome proliferator-activated receptor δ to reduce free radicals and alleviate cardiac hypertrophy induced by hyperglycemia in cultured H9c2 cells. J Cell Biochem. 2018; 119:9532–42. ChengK-C ChangW-T LiY ChengY-Z ChengJ-T ChenZ-C GW0742 activates peroxisome proliferator-activated receptor δ to reduce free radicals and alleviate cardiac hypertrophy induced by hyperglycemia in cultured H9c2 cells J Cell Biochem 2018 119 9532 42 10.1002/jcb.2727030129179 Search in Google Scholar

[20] Chandrasekar B, Mummidi S, Claycomb WC, Mestril R, Nemer M. Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signaling pathway in cardiomyocytes. J Biol Chem. 2005; 280:4553–67. ChandrasekarB MummidiS ClaycombWC MestrilR NemerM Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signaling pathway in cardiomyocytes J Biol Chem 2005 280 4553 67 10.1074/jbc.M41178720015574430 Search in Google Scholar

[21] Chandrasekar B, Boylston WH, Venkatachalam K, Webster NJ, Prabhu SD, Valente AJ. Adiponectin blocks interleukin-18-mediated endothelial cell death via APPL1-dependent AMP-activated protein kinase (AMPK) activation and IKK/NF-κB/PTEN suppression. J Biol Chem. 2008; 283:24889–98. ChandrasekarB BoylstonWH VenkatachalamK WebsterNJ PrabhuSD ValenteAJ Adiponectin blocks interleukin-18-mediated endothelial cell death via APPL1-dependent AMP-activated protein kinase (AMPK) activation and IKK/NF-κB/PTEN suppression J Biol Chem 2008 283 24889 98 10.1074/jbc.M804236200325983118632660 Search in Google Scholar

[22] Freund C, Schmidt-Ullrich R, Baurand A, Dunger S, Schneider W, Loser P, et al. Requirement of nuclear factor-κB in angiotensin II– and isoproterenol-induced cardiac hypertrophy in vivo. Circulation. 2005; 111:2319–25. FreundC Schmidt-UllrichR BaurandA DungerS SchneiderW LoserP Requirement of nuclear factor-κB in angiotensin II– and isoproterenol-induced cardiac hypertrophy in vivo Circulation 2005 111 2319 25 10.1161/01.CIR.0000164237.58200.5A15870116 Search in Google Scholar

[23] Nakagawa Y, Nishikimi T, Kuwahara K. Atrial and brain natriuretic peptides: hormones secreted from the heart. Peptides. 2019; 111:18–25. doi: 10.1016/j.peptides.2018.05.012 NakagawaY NishikimiT KuwaharaK Atrial and brain natriuretic peptides: hormones secreted from the heart Peptides 2019 111 18 25 10.1016/j.peptides.2018.05.012 29859763 Open DOISearch in Google Scholar

[24] Murray DR, Mummidi S, Valente AJ, Yoshida T, Somanna NK, Delafontaine P, et al. β2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo. J Mol Cell Cardiol. 2012; 52:206–18. MurrayDR MummidiS ValenteAJ YoshidaT SomannaNK DelafontaineP β2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo J Mol Cell Cardiol 2012 52 206 18 10.1016/j.yjmcc.2011.09.022324602622004899 Search in Google Scholar

[25] Lagha AB, Grenier D. Tea polyphenols inhibit the activation of NF-κB and the secretion of cytokines and matrix metalloproteinases by macrophages stimulated with Fusobacterium nucleatum. Sci Rep. 2016; 6:34520. doi: 10.1038/srep34520 LaghaAB GrenierD Tea polyphenols inhibit the activation of NF-κB and the secretion of cytokines and matrix metalloproteinases by macrophages stimulated with Fusobacterium nucleatum Sci Rep 2016 6 34520 10.1038/srep34520 504613427694921 Open DOISearch in Google Scholar

[26] Hao J, Kim C-H, Ha T-S, Ahn H-Y. Epigallocatechin-3 gallate prevents cardiac hypertrophy induced by pressure overload in rats. J Vet Sci. 2007; 8:121–9. HaoJ KimC-H HaT-S AhnH-Y Epigallocatechin-3 gallate prevents cardiac hypertrophy induced by pressure overload in rats J Vet Sci 2007 8 121 9 10.4142/jvs.2007.8.2.121287270917519564 Search in Google Scholar

[27] Planavila A, Laguna JC, Vázquez-Carrera M. Nuclear factor-κB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy. J Biol Chem. 2005; 280:17464–71. PlanavilaA LagunaJC Vázquez-CarreraM Nuclear factor-κB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy J Biol Chem 2005 280 17464 71 10.1074/jbc.M41422020015728586 Search in Google Scholar

[28] Planavila A, Rodríguez-Calvo R, Jové M, Michalik L, Wahli W, Laguna JC, Vázquez-Carrera M. Peroxisome proliferator-activated receptor β/δ activation inhibits hypertrophy in neonatal rat cardiomyocytes. Cardiovasc Res. 2005; 65:832–41. PlanavilaA Rodríguez-CalvoR JovéM MichalikL WahliW LagunaJC Vázquez-CarreraM Peroxisome proliferator-activated receptor β/δ activation inhibits hypertrophy in neonatal rat cardiomyocytes Cardiovasc Res 2005 65 832 41 10.1016/j.cardiores.2004.11.01115721863 Search in Google Scholar

[29] Nebigil CG, Maroteaux L. Functional consequence of serotonin/5-HT_2B receptor signaling in heart: role of mitochondria in transition between hypertrophy and heart failure? Circulation. 2003; 108:902–8. NebigilCG MaroteauxL Functional consequence of serotonin/5-HT_2B receptor signaling in heart: role of mitochondria in transition between hypertrophy and heart failure? Circulation 2003 108 902 8 10.1161/01.CIR.0000081520.25714.D912925446 Search in Google Scholar

[30] Dinarello CA, Novick D, Kim S, Kaplanski G. Interleukin-18 and IL-18 binding protein. Front Immunol. 2013; 4:289. doi: 10.3389/fimmu.2013.00289 DinarelloCA NovickD KimS KaplanskiG Interleukin-18 and IL-18 binding protein Front Immunol 2013 4 289 10.3389/fimmu.2013.00289 379255424115947 Open DOISearch in Google Scholar